Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 41 - 50 of 121
Active Status: No
User: Male
Mode: No
Delivery Type: Oral
Developer: WHO, South-to-South Cooperation in Reproductive Health
Project Stage: Phase I
Alternative Name: SARM C-6
Active Status: No
User: Male
Mode: Yes
Delivery Type: Oral
Developer: GTx, Inc., Memphis, TN
Project Stage: Pre-clinical
Alternative Name: H2-GMZ
Active Status: Yes
User: Male
Mode: No
Delivery Type: Oral
Developer: University of Kansas Medical Center, University of Minnesota
Project Stage: Pre-clinical
Alternative Name: Injectable Gestodene (GES) + Ethinyl Estradiol (EE)
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Peking University
Project Stage: Pre-clinical
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: Stanford University
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: University of California San Diego
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: KYDES Pharmaceuticals, FHI 360
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Injectable
Developer: University of Tennessee Health Sciences Center
Project Stage: Pre-clinical
Alternative Name: Gendarussa
Active Status: Yes
User: Male
Mode: No
Delivery Type: Oral
Developer: Airlangga University, Indopharma, FHI 360
Project Stage: Phase II
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: ContraMed, LLC
Project Stage: Phase II

Pages

CSV